Durability of insulin degludec plus liraglutide versus insulin glargine U100 as initial injectable therapy in type 2 diabetes (DUAL VIII): a multicentre, open-label, phase 3b, randomised controlled trial
Aroda, Vanita R, González-Galvez, Guillermo, Grøn, Randi, Halladin, Natalie, Haluzík, Martin, Jermendy, György, Kok, Adri, Őrsy, Petra, Sabbah, Mohamed, Sesti, Giorgio, Silver, RobertLanguage:
english
Journal:
The Lancet Diabetes & Endocrinology
DOI:
10.1016/S2213-8587(19)30184-6
Date:
June, 2019
File:
PDF, 1.90 MB
english, 2019